Attached files

file filename
10-Q - FORM 10-Q - Aegerion Pharmaceuticals, Inc.d943604d10q.htm
EX-10.2 - EX-10.2 - Aegerion Pharmaceuticals, Inc.d943604dex102.htm
EX-10.1 - EX-10.1 - Aegerion Pharmaceuticals, Inc.d943604dex101.htm
EX-10.3 - EX-10.3 - Aegerion Pharmaceuticals, Inc.d943604dex103.htm
EX-32.2 - EX-32.2 - Aegerion Pharmaceuticals, Inc.d943604dex322.htm
EX-31.1 - EX-31.1 - Aegerion Pharmaceuticals, Inc.d943604dex311.htm
EX-31.2 - EX-31.2 - Aegerion Pharmaceuticals, Inc.d943604dex312.htm

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

This certification set forth below is hereby made solely for the purpose of satisfying the requirements of Section 906 of the Sarbanes-Oxley Act of 2002 and may not be relied upon or used for any other purposes.

In connection with the Quarterly Report of Aegerion Pharmaceuticals, Inc. (the “Company”) on Form 10-Q for the period ended June 30, 2015, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Sandford D. Smith, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge: (1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and (2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

A signed original of this written statement required by Section 906 or other document authenticating, acknowledging or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

Date: August 17, 2015     By:  

/s/ Sandford D. Smith

     

Sandford D. Smith

Chief Executive Officer (principal executive officer) and Director